New Guidelines to Make Psychedelic Trials Safer, FDA-Ready

An international expert panel has developed the first consensus-based framework for reporting “set and setting” variables in psychedelic clinical trials. The guidelines create a standardized protocol for psychedelic clinical trials that accounts for the mental state of the user and the environment in which the psychedelic experience takes place…